Clinical Trials Browser

Phase 2 × Carcinoma, Transitional Cell × PM 01183 × Clear all

NCT05574504 2024-08-01

Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy

Phase 2 Withdrawn

Carcinoma, Transitional Cell, Neoplasm Metastasis